| 标题 |
 COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study 相关领域
医学
内科学
肺癌
化疗
风险评估
癌症
腺癌
血液学
静脉血栓栓塞
肿瘤科
胃肠病学
疾病
弗雷明翰风险评分
肺栓塞
呼吸道疾病
回顾性队列研究
风险因素
流行病学
血管疾病
外科
|
| 网址 | |
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 |
COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment … COMPASS-CAT 与 Khorana 风险评估模型，用于预测积极治疗非小细胞肺癌患者的静脉血栓栓塞事件...... H Abdel-Razeq, B Sharaf, MJ Al-Jaghbeer, H Abu-Fares, R Bater, MA Shaer, H Abu-Jaish… Journal of Thrombosis and Thrombolysis, 2023•Springer Abstract 抽象 Cancer patients are at higher risk for venous thromboembolism (VTE). Several risk assessment models (RAM), including the Khorana and COMPASS-CAT, were developed to help predict the occurrence of VTE in cancer patients on active anti-cancer therapy. We aim to study the prevalence and predictors of VTE among patients with non-small cell lung cancer (NSCLC) and compare both RAMs in predicting VTE in patients with NSCLC were retrospectively reviewed. Variables known to increase the risk of VTE were collected and |
| 求助人 | |
| 下载 | |
|
温馨提示：该文献已被科研通 学术中心 收录，前往查看
科研通『学术中心』是文献索引库，收集文献的基本信息（如标题、摘要、期刊、作者、被引量等），不提供下载功能。如需下载文献全文，请通过文献求助获取。
|
浮游
changping
小青椒
tuanheqi
彭于彦祖
zcl
star
LPPQBB
eric888
子车茗
无心客
GingerF
Smar_zcl
哈基米德
Criminology34
Li
chenqiumu
嘻嘻哈哈
不配.
竹筏过海
pcr163
遇上就这样吧
xxfsx
风吹麦田
皖公网安备34019202002308
